Reuters logo
Teva Pharm announces settlement of generic Avandia, Avandamet, and Avandaryl litigation with GlaxoSmithKline
September 27, 2007 / 10:12 PM / in 10 years

Teva Pharm announces settlement of generic Avandia, Avandamet, and Avandaryl litigation with GlaxoSmithKline

Co announced that the District Court case has been settled on terms that are confidential allowing TEVA by license to enter the U.S. market with its generic versions of Avandia (Rosiglitazone Maleate), Avandamet (Rosiglitazone Maleate/Metformin HCl) and Avandaryl (Rosiglitazone Maleate/Glimepiride) oral tablets late in Q1, 2012.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below